Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Plywaczewski, P. Bielen, A. Skoczylas, M. Czystowska, D. Gorecka, P. Sliwinski (Warsaw, Poland). Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity. Eur Respir J 2008; 32: Suppl. 52, 3242

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnoea (OSA) and hypothyroidism Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011 Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Obstructive sleep apnea syndrome (OSAS) and asthma in a general Norwegian population Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Obstructive sleep apnoea (OSA) in the elderly Source: Eur Respir J 2002; 20: Suppl. 38, 575s Year: 2002 Obstructive sleep apnea and metabolic syndrome in thin patients; characteristics and comparation with patients with overweight and obesity Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019 Obstructive sleep apnea-hypopnea syndrome in patients with asthma Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities? Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013 Socioeconomic status and obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Obstructive sleep apnea syndrome (OSAS). Value of cardiovascular markers (CM) to detect arousals Source: Eur Respir J 2003; 22: Suppl. 45, 272s Year: 2003 Obstructive sleep apnea syndrome as a cause of uncontrolled nocturnal asthma Source: Eur Respir J 2004; 24: Suppl. 48, 114s Year: 2004 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017